SEC Form 4 · accession 0001209191-18-036719
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Stack
Officer — CEO and Chairman · Director
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2018 | S | 8,615 | $35.61 | D | 91,831 | D | |
| Common StockF3 | Jun 7, 2018 | S | 7,191 | $36.63 | D | 84,640 | D | |
| Common StockF4 | Jun 7, 2018 | S | 2,600 | $37.53 | D | 82,040 | D | |
| Common StockF5 | holding | — | — | — | 18,596 | I | By Stack Schroon Mohawk FLP | |
| Common StockF5 | holding | — | — | — | 1,208 | I | By LCK Investment LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- F2These sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $37.15, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.25 to $37.95, inclusive.
- F5Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.